These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34559414)

  • 1. 1,2,3-Triazole hybrids as anticancer agents: A review.
    Alam MM
    Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100158. PubMed ID: 34559414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
    Xu Z; Zhao SJ; Liu Y
    Eur J Med Chem; 2019 Dec; 183():111700. PubMed ID: 31546197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural modification strategies of triazoles in anticancer drug development.
    Guan Q; Gao Z; Chen Y; Guo C; Chen Y; Sun H
    Eur J Med Chem; 2024 Sep; 275():116578. PubMed ID: 38889607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
    Yang M; Liu H; Zhang Y; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents.
    Wen X; Zhou Y; Zeng J; Liu X
    Curr Top Med Chem; 2020; 20(16):1441-1460. PubMed ID: 31994462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies.
    Turky A; Bayoumi AH; Sherbiny FF; El-Adl K; Abulkhair HS
    Mol Divers; 2021 Feb; 25(1):403-420. PubMed ID: 32830299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
    Zhang YZ; Liu HL; He QS; Xu Z
    Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis-triazole-containing Compounds with Anticancer Potential: A Short Review.
    Gao M; Diao Q; Gao F; Sun X; Xiao J
    Curr Top Med Chem; 2021; 21(18):1674-1691. PubMed ID: 34323190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent updates on 1,2,3-triazole-containing hybrids with in vivo therapeutic potential against cancers: A mini-review.
    Zhao S; Liu J; Lv Z; Zhang G; Xu Z
    Eur J Med Chem; 2023 May; 251():115254. PubMed ID: 36893627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of 1,2,3-triazole hybrids for leukemia treatment.
    Yang W; Xuan B; Li X; Si H; Chen A
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200106. PubMed ID: 35532286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triazole-fused pyrimidines in target-based anticancer drug discovery.
    Dai XJ; Xue LP; Ji SK; Zhou Y; Gao Y; Zheng YC; Liu HM; Liu HM
    Eur J Med Chem; 2023 Mar; 249():115101. PubMed ID: 36724635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel 1,2,3-triazole-pyrimidine-urea hybrids as potential anticancer agents.
    Ma LY; Wang B; Pang LP; Zhang M; Wang SQ; Zheng YC; Shao KP; Xue DQ; Liu HM
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1124-8. PubMed ID: 25655718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Development of Triazole Derivatives as Prospective Anticancer Agents: A Review.
    Sachdeva H; Saquib M; Tanwar K
    Anticancer Agents Med Chem; 2022; 22(19):3269-3279. PubMed ID: 35418291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advancements in 1,4-Disubstituted 1H-1,2,3-Triazoles as Potential Anticancer Agents.
    Lal K; Yadav P
    Anticancer Agents Med Chem; 2018; 18(1):21-37. PubMed ID: 27528183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cytotoxic evaluation of novel indenoisoquinoline-substituted triazole hybrids.
    Pham Thi T; Le Nhat TG; Ngo Hanh T; Luc Quang T; Pham The C; Dang Thi TA; Nguyen HT; Nguyen TH; Hoang Thi P; Van Nguyen T
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3652-7. PubMed ID: 27342752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
    Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
    Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 1,2,3-Triazole-Containing Hybrids as Antitumor Candidates: Design, Click Reaction Synthesis, DFT Calculations, and Molecular Docking Study.
    El Azab IH; El-Sheshtawy HS; Bakr RB; Elkanzi NAA
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33573040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors.
    El-Sherief HAM; Youssif BGM; Abbas Bukhari SN; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
    Eur J Med Chem; 2018 Aug; 156():774-789. PubMed ID: 30055463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
    Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
    Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds.
    Grytsai O; Valiashko O; Penco-Campillo M; Dufies M; Hagege A; Demange L; Martial S; Pagès G; Ronco C; Benhida R
    Bioorg Chem; 2020 Nov; 104():104271. PubMed ID: 32992279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.